Abnova (Taiwan) Corporation (TPE:4133)
26.80
-0.25 (-0.92%)
Jul 4, 2025, 1:35 PM CST
Abnova (Taiwan) Market Cap
Abnova (Taiwan) has a market cap or net worth of 1.62 billion as of July 3, 2025. Its market cap has decreased by -19.40% in one year.
Market Cap
1.62B
Enterprise Value
1.21B
Revenue
360.75M
Ranking
n/a
PE Ratio
33.49
Stock Price
26.80
Market Cap Chart
Since May 27, 2008, Abnova (Taiwan)'s market cap has decreased from 2.91B to 1.62B, a decrease of -44.22%. That is a compound annual growth rate of -3.35%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Caliway Biopharmaceuticals | 206.29B |
PharmaEssentia | 184.96B |
Bora Pharmaceuticals Co., LTD. | 83.16B |
Lotus Pharmaceutical | 58.37B |
Polaris Group | 30.62B |
Oneness Biotech | 30.51B |
Center Laboratories | 26.82B |
TaiMed Biologics | 25.15B |